Found 103 matching trials
Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01) NA Single-patient trial aiming to provide immunological consolidation followin...
Show More Learn More & Join Trial
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation PHASE1 This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Show More Status
Active Not Recruiting
Location
Childrens National Medical Center
Learn More & Join Trial
CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) PHASE1 The aim of this clinical trial is to evaluate the feasibility, safety and b...
Show More Location
Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum
Learn More & Join Trial
Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma PHASE1 In this study, investigators are trying to see if LMP specific cytotoxic T ...
Show More Location
Childrens National Medical Center
Learn More & Join Trial
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases PHASE1 Patients have a type of a lymph node cancer called lymphoma, a tumor of the...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies PHASE2 This is a Phase II trial to evaluate the efficacy and safety of human leuko...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation. NA The goal of this prospective clinical study is to evaluate the safety and e...
Show More Location
The Catholic University of Korea Seoul St.Mary's Hospital
Learn More & Join Trial
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies N/A The primary objective of this protocol is to provide expanded access to tab...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma PHASE1 RATIONALE: Biological therapies use different ways to stimulate the immune ...
Show More Location
Penn State Cancer Institute at Milton S. Hershey Medical Center
Learn More & Join Trial
EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC PHASE1 Epstein-Barr virus (EBV) infections is known to be a high-risk factor to in...
Show More Location
Department of Oncology, Xinqiao Hospital
Learn More & Join Trial